Sumatriptan and Centrum silver drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumatriptan (sumatriptan succinate) and Centrum silver (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e). Common drug interactions include nausea among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Sumatriptan and Centrum silver. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.

What is Sumatriptan?

Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 18,159 Sumatriptan users. Check the latest studies of Sumatriptan.

What is Centrum silver?

Centrum silver has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 19,997 Centrum silver users. Check the latest studies of Centrum silver.



On Jul, 26, 2026

56 people who take Sumatriptan and Centrum silver together, and have interactions are studied.

Sumatriptan and Centrum silver drug interactions.

What are the common drug interactions of Sumatriptan and Centrum Silver, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Breast cancer
  3. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  4. Defaecation urgency (a sudden compelling urge to defecate)
  5. Delusion (a false belief or opinion)
  6. Contusion (a type of hematoma of tissue in which capillaries)
  7. Road traffic accident
  8. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  9. Arthralgia (joint pain)
  10. Insomnia (sleeplessness)

male:

  1. Death
  2. Drug ineffective
  3. Flushing (the warm, red condition of human skin)
  4. Headache (pain in head)
  5. Hypersensitivity
  6. Nausea (feeling of having an urge to vomit)
  7. Tremor (trembling or shaking movements in one or more parts of your body)

What are the common drug interactions of Sumatriptan and Centrum Silver, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Flushing (the warm, red condition of human skin)
  2. Headache (pain in head)
  3. Hypersensitivity
  4. Nausea (feeling of having an urge to vomit)
  5. Tremor (trembling or shaking movements in one or more parts of your body)

50-59:

  1. Pulmonary mass
  2. Skin mass
  3. Somnolence (a state of near-sleep, a strong desire for sleep)
  4. White blood cell count decreased
  5. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  6. Delusion (a false belief or opinion)
  7. Disease progression
  8. Dyspnoea (difficult or laboured respiration)
  9. Fall
  10. Generalised oedema (swelling all over the body)

60+:

  1. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  2. Nausea (feeling of having an urge to vomit)
  3. Pelvi-ureteric obstruction (obstruction of the flow of urine from the renal pelvis to the proximal ureter)
  4. Vitamin d increased
  5. Ammonia increased
  6. Anxiety
  7. Asthenia (weakness)
  8. Death
  9. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  10. Defaecation urgency (a sudden compelling urge to defecate)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 13 people, 23.21%
  2. Gait Disturbance: 11 people, 19.64%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 17.86%
  4. Hypersensitivity: 9 people, 16.07%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 16.07%
  6. Muscle Spasms (muscle contraction): 9 people, 16.07%
  7. High Blood Cholesterol: 9 people, 16.07%
  8. Osteoporosis (bones weak and more likely to break): 8 people, 14.29%
  9. Osteopenia (a condition where bone mineral density is lower than normal): 7 people, 12.50%
  10. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 7 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan and Centrum silver?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sumatriptan and Centrum silver:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sumatriptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Centrum silver:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sumatriptan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Centrum silver and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate and ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e (the active ingredients of Sumatriptan and Centrum silver, respectively), and Sumatriptan and Centrum silver (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: